Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Propofol syndrome in children

Mark W. Crawford, Bruce G. Dodgson, Helen H.K. Holtby and W. Lawrence Roy
CMAJ March 18, 2003 168 (6) 669-669-a;
Mark W. Crawford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce G. Dodgson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen H.K. Holtby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Lawrence Roy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Eric Wooltorton's report about propofol1 reiterates the well-known fact that the use of propofol for sedation in critically ill children has been associated with a life-threatening adverse reaction characterized by metabolic acidosis, hemodynamic instability, multiorgan failure, lipemia, hepatomegaly and rhabdomyolysis.2,3 Wooltorton speculates that this reaction, which he refers to as the “propofol syndrome,” may be less common when the drug is used in children for procedural sedation or for induction or maintenance of general anesthesia. However, he contends that “significant harm can come from off-label use of agents whose pediatric safety profile is incomplete” and that “the known and theoretical risks of propofol should be explained to parents.”

At the Hospital for Sick Children, propofol has been used in approximately 100 000 pediatric patients for sedation and general anesthesia without a single occurrence of the “propofol syndrome.” This rate is less than the incidence of major perioperative complications.4 Our experience is similar to that at other centres,5,6 and thus the actual risk, if it exists at all, is minimal. Furthermore, a causal relation between propofol anesthesia and the syndrome has never been established.2,3,7

The suggestion that the “propofol syndrome” may occur in the context of single bolus administration or short-term infusion in children is incorrect. Accordingly, we stand by our practice of not citing this issue when we inform parents or guardians of the risks associated with propofol anesthesia in the preoperative interview.

Mark W. Crawford Director of Research Bruce G. Dodgson Director of Quality Management Helen H.K. Holtby Director of Cardiac Anesthesia W. Lawrence Roy Chief of Anesthesia Department of Anesthesia The Hospital for Sick Children Toronto, Ont.

References

  1. 1.↵
    Wooltorton E. Propofol: contraindicated for sedation of pediatric intensive care patients. CMAJ 2002; 167(5):507.
    OpenUrlFREE Full Text
  2. 2.↵
    Parke TJ, Stevens JE, Rice AS, Greenway CL, Bray RJ, Smith PJ, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613-6.
  3. 3.↵
    Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998;26:2087-92.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Cohen MM, Cameron CB, Duncan PG. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg 1990;70:160-7.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Hatch DJ. Propofol-infusion syndrome in children. Lancet 1999;353:1117-8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Reed MD, Blumer JL. Propofol bashing: The time to stop is now! Crit Care Med 1996;24:175-6.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet 1999;354:866-7.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 168, Issue 6
18 Mar 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Propofol syndrome in children
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Propofol syndrome in children
Mark W. Crawford, Bruce G. Dodgson, Helen H.K. Holtby, W. Lawrence Roy
CMAJ Mar 2003, 168 (6) 669-669-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Propofol syndrome in children
Mark W. Crawford, Bruce G. Dodgson, Helen H.K. Holtby, W. Lawrence Roy
CMAJ Mar 2003, 168 (6) 669-669-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlighting obesity as a risk factor for endometrial cancer
  • Hepatitis B vaccination for Canadian children: time for an adult conversation
  • Codesigning a public health approach to preventing firearm-related suicide deaths with rural communities
Show more Letters

Similar Articles

Collections

  • Topics
    • Pediatrics
    • Drugs: adverse reactions
    • Anesthesia & analgesia

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire